Communiqués Waters Corporation BOERSE MUENCHEN

Actions

WAZ

US9418481035

Equipement et technologie médicale avancés

Marché Fermé - BOERSE MUENCHEN Autres places de cotation 22:44:17 30/06/2026			Varia. 5j.	Varia. 1 janv.
329,80 ^EUR	+2,17%		+6,24%	+1,41%

25/06	SNT Biotech annonce un partenariat avec Waters Corporation pour proposer aux patientes américaines l'outil de dépistage à domicile du HPV le plus complet autorisé par la FDA	CI
24/06	IMU Biosciences choisit Waters Corporation pour propulser sa plateforme révolutionnaire de cartographie immunitaire par IA et transformer le diagnostic précoce	CI

Communiqués

24/06	IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine	PR
24/06	IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine	AQ
24/06	HighRes(R) and Waters Collaborate to Advance Drug Discovery through Robotic Automation	AQ
09/06	Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis	PR
09/06	Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis	AQ
08/06	Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis	PR
08/06	Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis	AQ
03/06	Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics	PR
03/06	Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics	AQ
01/06	Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research	PR
01/06	Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics	PR
01/06	Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics	AQ
01/06	Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research	AQ
18/05	Waters Corporation to Present at the Jefferies Global Healthcare Conference	PR
12/05	D. Mass. Patent Litigation Update: March 2026	AQ
05/05	Waters: Q1 Earnings Snapshot	AQ
05/05	Waters : First Quarter 2026 Non-GAAP Addendum	PU
05/05	Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results	PR
20/04	Waters Corporation Schedules First Quarter 2026 Earnings Conference Call	PR
14/04	Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules	PR
08/04	Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay	PR
18/03	Waters Prices Offering of Senior Notes	PR
09/03	Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed	PR
23/02	Waters Corporation to Present at the TD Cowen Health Care Conference	PR
17/02	Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage	PR